WiseChip Highlights OLED and TFT Display Solutions at CommunicAsia 2025
MIAOLI, May 27, 2025 /PRNewswire/ -- WiseChip Semiconductor Inc., a pioneer in PMOLED display technology with nearly 20 years of experience, is drawing attention at CommunicAsia 2025 with its latest OLED and TFT display innovations at Booth 3F3-12.
The showcased solutions target smart control, industrial computing, automotive electronics, and compact embedded devices, emphasizing high brightness, energy efficiency, and easy integration.
Featured OLED technologies include:
Mini Transparent OLED Modules: Sunlight-readable, ultra-thin displays with customizable icons for optical modules and HUDs.
Touch OLED Modules (In-Cell / Out-Cell): Slim, low-power modules for wearables, medical, and IoT applications, supporting intuitive gesture control.
High-Brightness, Low-Power OLEDs: Compact, self-emissive displays with wide temperature tolerance for embedded use.
Also on display are partner-developed systems:
Smart Cluster TFTs: 5"–10.3" LCDs with 1000-nit brightness, integrating driving data, DVR, and support for CarPlay/Android Auto.
Dual-Camera DVR Systems: 1080P modules with rider safety features like BSD, RCW, and LCA.
Industrial PCs: Intel® multi-core platforms with capacitive touch and IP65-rated panels for industrial environments.
"WiseChip is evolving from display hardware to system integration and user-centric design," said a spokesperson. "Together with our partners, we turn innovation into real-world solutions."
Live demos are available at Booth 3F3-12 through May 29.More info: www.wisechip.com.tw | Contact: MKT@wisechip.com.tw
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/wisechip-highlights-oled-and-tft-display-solutions-at-communicasia-2025-302465421.html
SOURCE WiseChip Semiconductor Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
44 minutes ago
- Business Wire
CARMAT Provides an Update on the Ongoing Receivership Procedure
PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the ' Company ' or ' CARMAT '), today provides an update on the ongoing receivership procedure and announces the suspension of trading in CARMAT shares, starting August 14, 2025, before stock market opening, ahead of the court hearing scheduled on August 19, 2025. Update on the ongoing receivership procedure Following a call for public tenders (buyers or investors) initiated as part of the receivership opened on July 1, 2025, the judiciary administrator had received, by the deadline of July 31, 2025, one takeover bid within the context of a sales plan (the 'Bid') 1. This Bid will be assessed by the Versailles Economic Court 2 (the "Court") at a hearing scheduled on August 19, 2025. The Company again draws attention to the fact that there is no guarantee at this stage that this Bid will be successful. The Company also reminds that even if the Bid is validated by the Court, the Company's shareholders and creditors may incur a significant loss of up to the total value of their investment or receivables. CARMAT is subject to a risk of liquidation, including in the short term. Suspension of CARMAT shares trading (ISIN code: FR0010907956, Ticker: ALCAR) Ahead of the court hearing scheduled on August 19, 2025, CARMAT has asked Euronext to suspend the trading of its shares starting on August 14, 2025, before the stock market opens. Another press release will be issued by the Company once the outcome of the court hearing is known. In any case, CARMAT endeavors to provide continuous support to patients who currently benefit from its Aeson® artificial heart. ●●● About CARMAT CARMAT is a French MedTech that designs, manufactures and markets the Aeson ® artificial heart. The Company's ambition is to make Aeson ® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage biventricular heart failure, who are facing a well-known shortfall in available human grafts. The world's first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson ® could save, every year, the lives of thousands of patients waiting for a heart transplant. The device offers patients quality of life and mobility thanks to its ergonomic and portable external power supply system that is continuously connected to the implanted prosthesis. Aeson ® is commercially available as a bridge to transplant in the European Union and other countries that recognize CE marking. Aeson ® is also currently being assessed within the framework of an Early Feasibility Study (EFS) in the United States. Founded in 2008, CARMAT is based in the Paris region, with its head offices located in Vélizy-Villacoublay and its production site in Bois-d'Arcy. The Company can rely on the talent and expertise of a multidisciplinary team of circa 200 highly specialized people. CARMAT is listed on the Euronext Growth market in Paris (Ticker: ALCAR / ISIN code: FR0010907956). For more information, please go to and follow us on LinkedIn. Disclaimer This press release and the information it contains do not constitute an offer to sell or subscribe, nor a solicitation of an offer to buy or subscribe, for CARMAT shares in any country. This press release may contain forward-looking statements regarding the Company's objectives and outlook. These forward-looking statements are based on the current estimates and anticipations of the Company's management and are subject to risk factors and uncertainties, including those described in its Universal Registration Document filed with the French Financial Markets Authority (Autorité des marchés financiers) (the 'AMF') under number D.25-0345 (the ' 2024 Universal Registration Document '), available free of charge on the websites of CARMAT ( and the AMF ( Readers' attention is particularly drawn to the fact that the Company is currently placed in receivership (opened on July 1, 2025) and is facing a risk of liquidation including in the very short term. The Company is also exposed to other risks and uncertainties, such as its ability to implement its strategy, the pace of development of its production and sales, the progress and results of ongoing or planned clinical trials, technological developments, the competitive landscape, regulatory changes, industrial risks, and all risks related to the management of the Company's growth. Forward-looking statements mentioned in this press release may not be achieved due to these factors or other unknown risks and uncertainties, or risks that the Company does not currently consider to be material or specific. Aeson® is an active implantable medical device commercially available in the European Union and other countries recognising the CE mark. The Aeson® total artificial heart is intended to replace the ventricles of the native heart and is indicated as a bridge to transplant in patients with end-stage biventricular heart failure (Intermacs classes 1-4) who cannot benefit from maximal medical therapy or a left ventricular assist device (LVAD) and who are likely to benefit from a heart transplant within 180 days of implantation. The decision to implant and the surgical procedure must be carried out by healthcare professionals trained by the manufacturer. The documentation (clinician's manual, patient's manual and alarm booklet) must be read carefully to learn about the characteristics of Aeson® and the information required for patient selection and proper use (contraindications, precautions, side effects) of Aeson®. In the United States, Aeson® is currently only available as part of a feasibility clinical trial approved by the Food & Drug Administration (FDA). 1 Offre de reprise en plan de cession » (in French). 2 Tribunal des Activités Economiques de Versailles.
Android Authority
44 minutes ago
- Android Authority
Is your Android Auto screen suddenly a washed-out nightmare? You're not alone
TL;DR Android Auto users claim that a recent update has created a contrast problem. The reports claim that displays now appear washed out. The problem is bad enough that some users thought the change was a design choice. It's difficult not to notice when a display suddenly changes from showing rich colors to being washed out. If you're someone who cares about how your screen looks, it can be incredibly unpleasant to have to look at a panel where blacks now look grey. This is a problem that appears to be affecting multiple Android Auto users after a recent update. Don't want to miss the best from Android Authority? Set us as a preferred source in Google Search to support us and make sure you never miss our latest exclusive reports, expert analysis, and much more. Over on Reddit, Android Auto users are reporting that a recent update may have caused the contrast on their screens to go haywire. The displays look so washed out that some users thought this bug was an intentional design change by Google. It also appears that you can't fix the problem by adjusting your vehicle display settings. One user says, 'Everything is so faded now, as if someone cranked the contrast to 11.' 'It's so annoying and I can't find a fix at all, it just looks complete garbage now and it especially bad at night,' another user replied. 'REALLY wanting a fix for this ASAP, it was miles better before some update has ruined it.' If you're running into this problem as well, there may be a temporary fix. One commenter claims that clearing data and cache from the Android Auto app tends to work in the short term. Android Authority has contacted Google about the issue and whether a long-term fix is on the way. We'll provide an update on this situation as soon as new information is available. Follow
Business Wire
an hour ago
- Business Wire
AN Supps Expands Innovation With Iconic Chiquita® Brand Collab and a Nationwide Walmart U.S. Launch
NASHVILLE, Tenn.--(BUSINESS WIRE)--With the indulgence of beach barbeques and happy hours fading into rear view mirrors, consumers will stock up on health and wellness related foods and beverages, while shopping for the Fall. AN Supps, a division of Applied Nutrition PLC, has responded to this trend - joining forces with Chiquita® Brands International and thousands of Walmart U.S. stores to deliver protein and pre-workout sports beverage mixes. AN Supps began its partnership with Chiquita® earlier in 2025, with five co-branded sports nutrition products exclusively sold through The Vitamin Shoppe. The expanded partnership through Walmart allows shoppers to enjoy not only nutritious, healthy supplements so simple to use – but also a great-tasting source for beverage and food snacks, suited for many lifestyles. The AN ESSENTIAL line of Chiquita® co-branded sports nutrition powders, exclusively from AN Supps, is now available at thousands of Walmart locations in the United States, and on 'This partnership evolved naturally,' remarked Aaron Heidebreicht, CEO of AN Supps. 'Bananas are the world's most popular fruit. Walmart already sells over three billion bananas annually in the United States alone. We are determined to address unmet demand in our own aisles. The Chiquita® banner helps us to reinforce the integrity and quality of our sports nutrition, as Chiquita does with its core product.' Heidebreicht continued. 'Each offering delivers on natural flavors – and a serving of each protein powder has 100% of the potassium found in a banana. We are giving wellness consumers the solution they need elsewhere in a Walmart location. Plus, the protein product, like any Chiquita® banana, tastes delicious.' Walmart will be offering two protein powders from AN Supps, featuring the Chiquita co-branding – a banana chocolate whey protein, and a banana strawberry whey protein. Both are gluten-free, potassium enriched, and servings from each contain 20 grams of protein. AN Supps will further celebrate the bevy of fresh fruit that also define the Chiquita® brand equity. Chiquita® distributes fresh apples, berries, pineapples, grapes, melon and citrus worldwide. These inspire two additional Chiquita® co-branded items at Walmarts nationwide: pineapple strawberry and fruit blend pre-workout powders. Much like the Chiquita® fruits inspiring these powders, both are gluten-free, soy-free, vegan-friendly, and with no added sugar. 'Chiquita® has been meticulous in its approach to extending across aisles at retail chains as prestigious as Walmart,' said Maria Janis, Vice-President, Licensing at Chiquita® Brands International. "We ask ourselves introspectively: Does the new category complement wholesome nutrition? Will it appeal to a wide demographic? Do the ingredient and flavor profiles align with Chiquita® fresh produce we ship worldwide? Does the new category reinforce our brand's wellness values? And importantly, will the product meet the needs of critical stakeholders – our shoppers and the retail chains they frequent? The AN Supps line, quite simply, checks all the boxes,' Janis remarked. 'Applied Nutrition PLC is a public company traded on the London Stock Exchange,' continued Heidebreicht. "Our stockholders mandate us to innovate and surpass consumer expectations, while paying homage to the trademark brands that long achieved those goals. We benefit in multiple ways through our strategic alliance with Chiquita® Brands International, and with Walmart locations throughout the United States. This extends our global alliance with these partners, which consumers everywhere continue to enjoy,' Heidebreicht said. The four AN Supps SKUs at Walmart U.S. locations, co-branded with Chiquita®, include banana-chocolate whey protein; banana-strawberry whey protein; pineapple-strawberry pre-workout powder; and fruit blend pre-workout powder. About Chiquita® Brands International Chiquita® is a leading global produce company that is committed to providing both consumers and customers across nearly 70 countries with the highest quality of fruit and service, making Chiquita® the banana of choice. For more than 150 years, Chiquita® has been proudly producing great-tasting, superior quality bananas. The brand creates a positive impact by implementing the principles of sustainability throughout all of its business practices under the "Behind the Blue Sticker" initiative. The iconic Blue Sticker has been the seal of approval for high-quality fruit, and a celebration of fun, but it also represents an unwavering commitment to sustainable farming, biodiversity and giving back to the communities in which the banana plantations operate. Great-tasting and convenient Chiquita® bananas are fat-free, and provide a source of potassium, fiber and vitamin B6. To learn more, visit About Applied Nutrition PLC Applied Nutrition PLC, is a leading sports nutrition, health and wellness brand, which formulates and creates nutrition products targeted at a wide range of consumers and sold in over 80 countries worldwide. Its vision is to be the world's most trusted and innovative sports nutrition, health & wellness brand. The values at Applied Nutrition reflect our passion for health, wellbeing and integrity. Applied Nutrition PLC, and its North American division, AN Supps, are committed to excellence, fostering a positive and supportive environment for both its team and its customers. By maintaining the highest standards, Applied Nutrition PLC ensures that every product and service we provide reflects our passion for health, integrity, and innovation. On 29 October, 2024, Applied Nutrition PLC was admitted to the London Stock Exchange. To learn more, visit and
